家禽用ワクチンの世界市場

家禽用ワクチンの世界市場は2030年までに32億米ドルに到達

2024年に23億米ドルと推定される家禽用ワクチンの世界市場は、分析期間2024-2030年にCAGR 5.8%で成長し、2030年には32億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである改良/弱毒化生ワクチンは、CAGR 6.2%を記録し、分析期間終了時には21億米ドルに達すると予測されます。不活化ワクチン分野の成長率は、分析期間中CAGR 4.5%と推定されます。

米国市場は6億3,180万米ドルと推定、中国はCAGR 9.2％で成長予測

米国の家禽用ワクチン市場は、2024年には6億3,180万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに6億5,900万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.2%です。その他の注目すべき地域市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.8%と5.7%と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界の家禽用ワクチン市場- 主要動向と促進要因のまとめ

家禽用ワクチンが近代養鶏の中心になりつつある理由とは？

家禽用ワクチンは、ニワトリ、トルコ、アヒル、ガチョウなどの鳥類に様々な感染症に対する免疫をつけるために使用される生物学的製剤です。これらのワクチンは、ニューカッスル病、鳥インフルエンザ、伝染性気管支炎、マレック病、家禽コレラなどの病気を予防する上で極めて重要です。病気や生産システムによって、ワクチンには弱毒生ワクチン、不活化ワクチン、組み換えワクチン、ベクターベースのものがあります。これらのワクチンは、注射、飲料水、散布、またはin ovo技術によって投与され、群れの中で個体免疫と群れ免疫の両方を提供します。

家禽製品の世界の需要が増加し続ける中、大規模で健康な家禽群を維持することは、これまで以上に重要になってきています。疾病の発生は壊滅的な損失を引き起こし、家禽生産者に経済的な影響を与えるだけでなく、食品サプライチェーンを混乱させることもあります。ワクチン接種は、総合的な家禽衛生管理システムにおいて不可欠な要素となっており、死亡率を下げ、疾病伝染を制限し、全体的な生産性を向上させるのに役立っています。商業経営においては、ワクチンは、抗生物質や反応性治療に頼る従来の方法に取って代わり、疾病の脅威から身を守る第一線と見なされるようになってきています。

技術革新と消費者の嗜好はどのように市場を形成しているのか？

家禽ワクチン市場は、科学技術の革新と消費者の要求の進化によって再構築されつつあります。技術面では、分子生物学の進歩により、組換えワクチンやベクターベースのワクチンが開発され、副作用を最小限に抑えながら、より標的を絞った持続性のある免疫が得られるようになりました。in ovoや自動エアロゾルベースのシステムなど、新たな送達方法により、大量ワクチン接種がより迅速かつ効率的になり、鳥類へのストレスも軽減されつつあります。常時冷蔵を必要としない耐熱性ワクチンは、遠隔地や資源が限られた地域での幅広いアクセスを可能にし、主要な物流障壁に対処しています。

消費者の期待の変化も、家禽用ワクチンの認識や使用方法に影響を与えています。抗生物質耐性や食品中の残留化学物質に対する懸念が高まる中、鶏肉生産者は、抗生物質不使用やオーガニック鶏肉生産へのシフトに沿った、持続可能な疾病予防策としてワクチン接種を採用しています。これと並行して、食品生産におけるトレーサビリティと透明性が、ワクチン接種プログラムにおけるデジタル追跡システムの統合につながり、リアルタイムのモニタリング、投与量の正確さ、そしてより優れたアウトブレイク対応を可能にしています。こうした技術革新により、家禽類のワクチン接種は、より戦略的で測定可能なものとなり、食品安全および動物福祉におけるより広範な動向との整合性が図られつつあります。

家禽用ワクチン市場の成長はいくつかの要因によって牽引されている....

家禽用ワクチン市場の成長はいくつかの要因によって牽引されているが、その主な要因は、商業的および裏庭的農業経営における感染性家禽疾病の蔓延の増加です。群れのサイズが大きくなり、より集約的な農業システムにより、疾病蔓延のリスクは著しく高まっており、予防ワクチン接種が必要不可欠となっています。もうひとつの重要な要因は、安全で高品質な鶏肉製品に対する需要の高まりであり、これが生産者を抗生物質の治療的使用からワクチン接種のような予防衛生戦略へと向かわせた。

さらに、組換えDNAワクチンや多価ワクチンなど、先進的なワクチン技術の開発により、生産者はより柔軟で効果的な防疫ソリューションを提供できるようになっています。これらの技術革新により、必要なワクチン接種の回数が減り、免疫応答が改善されるため、ワクチン接種プログラムがより費用対効果に優れ、管理しやすくなっています。サーベイランス・プログラムやワクチン接種への助成金など、動物衛生への取り組みに対する政府の支援が拡大している地域も、普及に寄与しています。最後に、死亡率の減少、飼料要求率の改善、安定した生産性など、ワクチンの経済的・健康的メリットに関する養鶏農家の意識の高まりが、世界の家禽用ワクチン市場の持続的拡大に拍車をかけています。

セグメント

ワクチンタイプ（改良/弱毒化生ワクチン,不活化ワクチン,その他のワクチンタイプ）、疾病タイプ（感染性気管支炎,感染性滑液包疾患,感染性喉頭気管炎,卵落下症候群,アデノウイルス,カモウイルス,腸炎,封入体肝炎,コクシジウム症,鳥インフルエンザ,マレック病,ニューカッスル病,サルモネラ,鳥脳脊髄炎,家禽コレラ）、投与ルート（注射投与ルート、経鼻投与ルート）、流通チャネル（小売流通チャネル、eコマース流通チャネル、病院/クリニック薬局）、用途（ブリーダー用途、ブロイラー用途、レイヤー用途）

調査対象企業の例

• Anicon Labor GmbH
• Biovac
• Biovet Pvt Ltd
• Boehringer Ingelheim International GmbH
• Calier
• Ceva Sante Animale
• Deltamune
• Elanco Animal Health
• Hester Biosciences Limited
• HIPRA
• IDT Biologika GmbH
• Intervet Inc.（Subsidiary of Merck & Co., Inc.）
• KM Biologics（Meiji Animal Health）
• Merck Animal Health（MSD & Co., Inc.）
• Phibro Animal Health Corporation
• Tianjin Ringpu Bio-Technology Co., Ltd.
• Vaxxinova International BV
• Venky's（India）Limited
• Virbac
• Zoetis Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Poultry Vaccines Market to Reach US$3.2 Billion by 2030

The global market for Poultry Vaccines estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Modified / Attenuated Live Vaccine, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Inactivated Vaccine segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$631.8 Million While China is Forecast to Grow at 9.2% CAGR

The Poultry Vaccines market in the U.S. is estimated at US$631.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$659.0 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Poultry Vaccines Market - Key Trends & Drivers Summarized

Why Are Poultry Vaccines Becoming Central to Modern Poultry Farming?

Poultry vaccines are biological preparations used to immunize birds-such as chickens, turkeys, ducks, and geese-against various infectious diseases. These vaccines are crucial in preventing illnesses like Newcastle disease, avian influenza, infectious bronchitis, Marek’s disease, and fowl cholera. Depending on the disease and production system, vaccines can be live attenuated, inactivated, recombinant, or vector-based. They are administered via injection, drinking water, sprays, or in ovo techniques to offer both individual and herd immunity within flocks.

As the global demand for poultry products continues to rise, maintaining large and healthy flocks has become more critical than ever. Disease outbreaks can cause devastating losses, not only affecting poultry producers economically but also disrupting food supply chains. Vaccination has become an essential part of integrated poultry health management systems, helping reduce mortality rates, limit disease transmission, and improve overall productivity. In commercial operations, vaccines are increasingly seen as the first line of defense against disease threats, replacing older reliance on antibiotics and reactive treatments.

How Are Innovations and Consumer Preferences Shaping the Market?

The poultry vaccine market is being reshaped by scientific innovation and evolving consumer demands. On the technology front, advances in molecular biology have led to the development of recombinant and vector-based vaccines, which provide more targeted and durable immunity with minimal side effects. New delivery methods, including in ovo and automated aerosol-based systems, are making mass vaccination faster, more efficient, and less stressful for birds. Thermostable vaccines, which do not require constant refrigeration, are enabling broader access in remote and resource-limited regions, addressing a major logistical barrier.

Changing consumer expectations are also impacting how poultry vaccines are perceived and used. With growing concern over antibiotic resistance and chemical residues in food, poultry producers are adopting vaccination as a sustainable disease prevention measure that aligns with the shift toward antibiotic-free and organic poultry production. In parallel, traceability and transparency in food production have led to the integration of digital tracking systems in vaccination programs, allowing for real-time monitoring, dose precision, and better outbreak response. These innovations are making poultry vaccination more strategic, measurable, and aligned with broader trends in food safety and animal welfare.

The Growth in the Poultry Vaccines Market Is Driven by Several Factors……

The growth in the poultry vaccines market is driven by several factors, primarily the increased prevalence of infectious poultry diseases across commercial and backyard farming operations. With larger flock sizes and more intensive farming systems, the risk of disease spread has grown significantly, making preventive vaccination a necessity. Another key factor is the rising demand for safe and high-quality poultry products, which has pushed producers to move away from therapeutic antibiotic use and toward preventive health strategies like vaccination.

In addition, the development of advanced vaccine technologies, including recombinant DNA-based and multivalent vaccines, is offering producers more flexible and effective solutions for disease control. These innovations reduce the number of vaccinations needed and improve immune response, making vaccination programs more cost-effective and easier to manage. The growing government support for animal health initiatives, including surveillance programs and subsidies for vaccination in some regions, is also contributing to widespread adoption. Lastly, increased awareness among poultry farmers regarding the economic and health benefits of vaccines-such as reduced mortality, improved feed conversion, and consistent productivity-is fueling the sustained expansion of the poultry vaccines market worldwide.

SCOPE OF STUDY:

The report analyzes the Poultry Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Modified / Attenuated Live Vaccine, Inactivated Vaccine, Other Vaccine Types); Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral, Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera); Administration Route (Injectable Administration Route, Intranasal Administration Route); Distribution Channel (Retail Distribution Channel, E-Commerce Distribution Channel, Hospital / Clinic Pharmacies); Application (Breeder Application, Broiler Application, Layer Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Anicon Labor GmbH
• Biovac
• Biovet Pvt Ltd
• Boehringer Ingelheim International GmbH
• Calier
• Ceva Sante Animale
• Deltamune
• Elanco Animal Health
• Hester Biosciences Limited
• HIPRA
• IDT Biologika GmbH
• Intervet Inc. (Subsidiary of Merck & Co., Inc.)
• KM Biologics (Meiji Animal Health)
• Merck Animal Health (MSD & Co., Inc.)
• Phibro Animal Health Corporation
• Tianjin Ringpu Bio-Technology Co., Ltd.
• Vaxxinova International BV
• Venky's (India) Limited
• Virbac
• Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Poultry Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Expansion of Poultry Farming Operations Drives Demand for Vaccines
  • Increasing Awareness About Animal Health Propels Adoption of Vaccination Programs
  • Surge in Consumer Demand for Antibiotic-Free Poultry Products Strengthens Business Case for Vaccine Solutions
  • Rising Prevalence of Infectious Diseases in Poultry Accelerates Demand for Preventative Vaccination Solutions
  • Advancements in Vaccine Delivery Systems Propels Growth of Needle-Free and In-Feed Vaccines
  • Increasing Focus on Biosecurity Measures Drives Adoption of Comprehensive Vaccination Programs
  • Heightened Regulatory Scrutiny on Antibiotic Usage in Poultry Strengthens Market Demand for Vaccines
  • Growing Demand for Organic and Free-Range Poultry Drives Vaccine Market Expansion
  • Technological Advancements in Vaccines Spur Growth in Precision Vaccination and Personalized Approaches
  • Increased Investment in Research & Development Accelerates Innovation in Poultry Vaccines
  • Introduction of Novel Vaccines with Broader Efficacy Expands Addressable Market Opportunity
  • Rising Concerns About Food Safety and Disease Transmission Strengthens the Business Case for Poultry Vaccines
  • Expansion of Poultry Exports Stimulates Demand for Advanced Vaccination Solutions
  • Adoption of Digital Technologies in Poultry Farming Strengthens Vaccine Monitoring and Management Systems
  • Emergence of New Poultry Diseases Accelerates Research and Development of New Vaccines
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Poultry Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Modified / Attenuated Live Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Modified / Attenuated Live Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Modified / Attenuated Live Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Inactivated Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Inactivated Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Inactivated Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Enteritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Enteritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Enteritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Inclusion Body Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Inclusion Body Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Inclusion Body Hepatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Coccidiosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Coccidiosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Coccidiosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Avian Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Avian Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Avian Influenza by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Marek's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Marek's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Marek's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Newcastle Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Newcastle Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Newcastle Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Salmonella by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Salmonella by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Salmonella by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Avian Encephalomyelitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Avian Encephalomyelitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Avian Encephalomyelitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Fowl Cholera by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Fowl Cholera by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Fowl Cholera by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Infectious Bronchitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Infectious Bronchitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Infectious Bronchitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Infectious Bursal Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Infectious Bursal Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Infectious Bursal Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Infectious Laryngotracheitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Infectious Laryngotracheitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Infectious Laryngotracheitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Egg Drop Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Egg Drop Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Egg Drop Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Adenovirus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Adenovirus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Adenovirus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Duck Viral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Duck Viral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Duck Viral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Injectable Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Injectable Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Injectable Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Intranasal Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Intranasal Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Intranasal Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Retail Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Retail Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: World 15-Year Perspective for Retail Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 68: World Recent Past, Current & Future Analysis for E-Commerce Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: World Historic Review for E-Commerce Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: World 15-Year Perspective for E-Commerce Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 71: World Recent Past, Current & Future Analysis for Hospital / Clinic Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: World Historic Review for Hospital / Clinic Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: World 15-Year Perspective for Hospital / Clinic Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 74: World Recent Past, Current & Future Analysis for Breeder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: World Historic Review for Breeder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: World 15-Year Perspective for Breeder Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 77: World Recent Past, Current & Future Analysis for Broiler Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: World Historic Review for Broiler Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: World 15-Year Perspective for Broiler Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 80: World Recent Past, Current & Future Analysis for Layer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: World Historic Review for Layer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: World 15-Year Perspective for Layer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 83: USA Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: USA Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: USA 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 86: USA Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: USA Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: USA 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 89: USA Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: USA Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: USA 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 92: USA Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: USA Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: USA 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 95: USA Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: USA Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: USA 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 98: Canada Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Canada Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Canada 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 101: Canada Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Canada Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Canada 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 104: Canada Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Canada Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Canada 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 107: Canada Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Canada Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Canada 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 110: Canada Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Canada Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Canada 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• JAPAN
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 113: Japan Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Japan Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Japan 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 116: Japan Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Japan Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Japan 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 119: Japan Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Japan Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Japan 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 122: Japan Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Japan Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Japan 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 125: Japan Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Japan Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Japan 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• CHINA
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 128: China Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: China Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: China 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 131: China Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: China Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: China 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 134: China Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: China Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: China 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 137: China Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: China Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: China 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 140: China Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: China Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: China 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• EUROPE
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Europe Historic Review for Poultry Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Europe 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 146: Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Europe Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Europe 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 149: Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Europe Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Europe 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 152: Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Europe Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Europe 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 155: Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Europe Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Europe 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 158: Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Europe Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Europe 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• FRANCE
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 161: France Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: France Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: France 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 164: France Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: France Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: France 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 167: France Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: France Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: France 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 170: France Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: France Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: France 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 173: France Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: France Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: France 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• GERMANY
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 176: Germany Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Germany Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Germany 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 179: Germany Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Germany Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Germany 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 182: Germany Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Germany Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Germany 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 185: Germany Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Germany Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Germany 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 188: Germany Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Germany Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Germany 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 191: Italy Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Italy Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Italy 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 194: Italy Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Italy Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Italy 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 197: Italy Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Italy Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Italy 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 200: Italy Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Italy Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Italy 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 203: Italy Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Italy Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Italy 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 206: UK Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UK Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: UK 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 209: UK Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: UK Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: UK 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 212: UK Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: UK Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: UK 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 215: UK Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: UK Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: UK 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 218: UK Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: UK Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: UK 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 221: Spain Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Spain Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Spain 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 224: Spain Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Spain Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Spain 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 227: Spain Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Spain Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Spain 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 230: Spain Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Spain Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Spain 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 233: Spain Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Spain Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Spain 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 236: Russia Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Russia Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Russia 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 239: Russia Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Russia Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Russia 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 242: Russia Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Russia Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Russia 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 245: Russia Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Russia Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Russia 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 248: Russia Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Russia Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Russia 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 251: Rest of Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Europe Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Europe 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Europe Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Europe 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Europe Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Europe 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 260: Rest of Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Europe Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Europe 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Europe Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Europe Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Europe 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 266: Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 267: Asia-Pacific Historic Review for Poultry Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Asia-Pacific 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 269: Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Asia-Pacific Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Asia-Pacific 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 272: Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Asia-Pacific Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Asia-Pacific 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 275: Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Asia-Pacific Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Asia-Pacific 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 278: Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Asia-Pacific Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Asia-Pacific 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 281: Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Asia-Pacific Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Asia-Pacific 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 284: Australia Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Australia Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Australia 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 287: Australia Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Australia Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Australia 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 290: Australia Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Australia Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Australia 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 293: Australia Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Australia Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Australia 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 296: Australia Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Australia Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Australia 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• INDIA
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 299: India Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: India Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: India 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 302: India Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: India Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: India 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 305: India Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: India Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: India 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 308: India Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: India Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: India 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 311: India Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: India Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: India 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 314: South Korea Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: South Korea Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: South Korea 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 317: South Korea Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: South Korea Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: South Korea 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 320: South Korea Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: South Korea Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: South Korea 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 323: South Korea Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: South Korea Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: South Korea 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 326: South Korea Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: South Korea Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: South Korea 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 329: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Asia-Pacific Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Asia-Pacific 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Asia-Pacific Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Asia-Pacific 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 335: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Rest of Asia-Pacific Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Rest of Asia-Pacific 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 338: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Rest of Asia-Pacific Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Rest of Asia-Pacific 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 341: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Rest of Asia-Pacific Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Rest of Asia-Pacific 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 344: Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 345: Latin America Historic Review for Poultry Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Latin America 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 347: Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Latin America Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Latin America 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 350: Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Latin America Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Latin America 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 353: Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Latin America Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Latin America 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 356: Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Latin America Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Latin America 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 359: Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Latin America Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Latin America 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 362: Argentina Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Argentina Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Argentina 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 365: Argentina Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Argentina Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Argentina 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 368: Argentina Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Argentina Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Argentina 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 371: Argentina Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Argentina Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Argentina 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 374: Argentina Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Argentina Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Argentina 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 377: Brazil Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Brazil Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Brazil 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 380: Brazil Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Brazil Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Brazil 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 383: Brazil Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Brazil Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Brazil 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 386: Brazil Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Brazil Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Brazil 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 389: Brazil Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Brazil Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Brazil 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 392: Mexico Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Mexico Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Mexico 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 395: Mexico Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Mexico Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Mexico 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 398: Mexico Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Mexico Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Mexico 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 401: Mexico Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Mexico Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Mexico 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 404: Mexico Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Mexico Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Mexico 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 407: Rest of Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Latin America Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Latin America 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 410: Rest of Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Rest of Latin America Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Rest of Latin America 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 413: Rest of Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Rest of Latin America Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Rest of Latin America 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 416: Rest of Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Rest of Latin America Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Rest of Latin America 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 419: Rest of Latin America Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Rest of Latin America Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Rest of Latin America 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 422: Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 423: Middle East Historic Review for Poultry Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Middle East 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 425: Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Middle East Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Middle East 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 428: Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Middle East Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Middle East 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 431: Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Middle East Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Middle East 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 434: Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Middle East Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Middle East 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 437: Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Middle East Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Middle East 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 440: Iran Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Iran Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Iran 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 443: Iran Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Iran Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Iran 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 446: Iran Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Iran Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: Iran 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 449: Iran Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Iran Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: Iran 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 452: Iran Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Iran Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: Iran 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 455: Israel Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Israel Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: Israel 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 458: Israel Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Israel Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: Israel 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 461: Israel Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Israel Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: Israel 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 464: Israel Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: Israel Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: Israel 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 467: Israel Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: Israel Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: Israel 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 470: Saudi Arabia Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: Saudi Arabia Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: Saudi Arabia 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 473: Saudi Arabia Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: Saudi Arabia Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: Saudi Arabia 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 476: Saudi Arabia Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: Saudi Arabia Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: Saudi Arabia 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 479: Saudi Arabia Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Saudi Arabia Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: Saudi Arabia 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 482: Saudi Arabia Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Saudi Arabia Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: Saudi Arabia 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 485: UAE Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: UAE Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: UAE 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 488: UAE Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: UAE Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: UAE 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 491: UAE Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: UAE Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 493: UAE 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 494: UAE Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: UAE Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 496: UAE 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 497: UAE Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: UAE Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 499: UAE 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 500: Rest of Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Rest of Middle East Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 502: Rest of Middle East 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 503: Rest of Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Rest of Middle East Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 505: Rest of Middle East 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 506: Rest of Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 507: Rest of Middle East Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 508: Rest of Middle East 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 509: Rest of Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 510: Rest of Middle East Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 511: Rest of Middle East 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 512: Rest of Middle East Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 513: Rest of Middle East Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 514: Rest of Middle East 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030
• AFRICA
  • Poultry Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 515: Africa Recent Past, Current & Future Analysis for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 516: Africa Historic Review for Poultry Vaccines by Vaccine Type - Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 517: Africa 15-Year Perspective for Poultry Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccine, Inactivated Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 518: Africa Recent Past, Current & Future Analysis for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 519: Africa Historic Review for Poultry Vaccines by Disease Type - Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 520: Africa 15-Year Perspective for Poultry Vaccines by Disease Type - Percentage Breakdown of Value Sales for Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera, Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus and Duck Viral for the Years 2015, 2025 & 2030
  • TABLE 521: Africa Recent Past, Current & Future Analysis for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 522: Africa Historic Review for Poultry Vaccines by Administration Route - Injectable Administration Route and Intranasal Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 523: Africa 15-Year Perspective for Poultry Vaccines by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration Route and Intranasal Administration Route for the Years 2015, 2025 & 2030
  • TABLE 524: Africa Recent Past, Current & Future Analysis for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 525: Africa Historic Review for Poultry Vaccines by Distribution Channel - Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 526: Africa 15-Year Perspective for Poultry Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Retail Distribution Channel, E-Commerce Distribution Channel and Hospital / Clinic Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 527: Africa Recent Past, Current & Future Analysis for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 528: Africa Historic Review for Poultry Vaccines by Application - Breeder Application, Broiler Application and Layer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 529: Africa 15-Year Perspective for Poultry Vaccines by Application - Percentage Breakdown of Value Sales for Breeder Application, Broiler Application and Layer Application for the Years 2015, 2025 & 2030

IV. COMPETITION